Philogen SpA Sustainability Reports
Philogen S.p.A. is a biotechnology company that researches, develops, and produces biopharmaceuticals for treating high-unmet-need conditions like cancer and chronic inflammation. The company specializes in discovering tumor-targeting human monoclonal antibodies and small organic molecule ligands.
Sector: Manufacturing
Country: Italy
Exchange: Borsa Italiana (Euronext Milan)
LEI: 81560009EA1577917768
FIGI: BBG001SS9PV6
13 reports from 2020 to 2025
